Abstract:Circulation, Volume 146, Issue Suppl_1, Page A12541-A12541, November 8, 2022. Introduction:Sudden Unexpected Death in Epilepsy (SUDEP) is a leading cause of death in patients with epilepsy. While SUDEP mechanisms are not understood, there is evidence to implicate autonomic dysfunction and cardiac arrhythmias. Loss-of-function variants in SCN1A are linked to Dravet syndrome (DS). Importantly, SCN1A is expressed in both heart and brain in humans and rodents. Studies on Scn1a+/- DS mice and induced pluripotent stem cell (iPSC)-derived cardiac myocytes from DS patients show altered cardiac electrophysiology that serves as substrates for arrhythmias. However, no mouse or iPSC model can completely replicate the human DS phenotype.Hypothesis:Cardiac arrhythmias contribute to the mechanisms of SUDEP in a rabbit model of DS.Methods:We generate a New Zealand White (NZW) rabbit Scn1a deletion model using CRISPR-Cas9 gene editing. Rabbits were tested using video EEG/ECG telemetry as well as surface ECG under anesthesia. Optical mapping studies were performed in isolated hearts and patch clamp electrophysiology was performed in acutely isolated cardiac myocytes.Results:NZW Scn1a-/- kits died by postnatal day (P) 7-9 and showed bradycardia, long QT intervals, and AP prolongation. Cardiac myocytes isolated from NZW Scn1a+/- kits showed increased late sodium current compared to WT. We did not observe behavioral seizures or arrhythmias in NZW Scn1a+/- rabbits, which live normal life spans and breed normally. These data suggested, like mouse models, that the DS rabbit phenotype may be background strain dependent. To test this hypothesis, we crossed Scn1a+/- NZW rabbits to the Dutch Belted (DB) strain. We found that F1:NZW x DB Scn1a+/- rabbits have spontaneous seizures as well as pre- and post-ictal cardiac arrhythmia as assessed by video/EEG/ECG telemetry. Approximately 22% of the kits undergo premature death. Severe seizures are observed in adult animals, but to date no adults have died during seizures.Conclusions:F1:NZW x DB Scn1a+/- rabbits model DS in terms of seizures and SUDEP and are an optimal model to investigate neuro-cardiac mechanisms of SUDEP as well as to develop novel therapeutics for DS. To our knowledge, this is the first transgenic large animal model of a developmental and epileptic encephalopathy

Knock-in Kcnh2 Rabbit Model of Long QT Syndrome Type-2, Epilepsy, and Sudden Death

KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome

Abstract 12541: Development of a Transgenic Rabbit Model of Dravet Syndrome

A knock-in mouse model for KCNQ2-related epileptic encephalopathy displays spontaneous generalized seizures and cognitive impairment

Identification and characterization of two novel KCNH2 mutations contributing to long QT syndrome

Novel Compound Heterozygous Mutations in the KCNQ1 Gene Associated with Autosomal Recessive Long QT Syndrome (jervell and Lange‐Nielsen Syndrome)

KCNQ1-deficient and KCNQ1-mutant human embryonic stem cell-derived cardiomyocytes for modeling QT prolongation

Identification of A Kir3.4 Mutation in Congenital Long Qt Syndrome

Molecular, cellular, and functional analysis of a novel long QT type 2 deletion

Epilepsy phenotype and response to KCNQ openers in mice harboring the Kcnq2 R207W voltage-sensor mutation

Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues

Simulation of KCNJ2-linked Short QT Syndrome in Human Ventricular Tissue.

The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of Short QT Syndrome type 3

Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture

Suppression and Replacement Gene Therapy for KCNH2-Mediated Arrhythmias.

Torsades De Pointes Electrical Storm in Children with KCNH2 Mutations

Electrophysiological Characteristics of the LQT2 Syndrome Mutation KCNH2-G572S and Regulation by Accessory Protein KCNE2

Computational Analysis of Long QT Syndrome Type 2 and the Therapeutic Effects of KCNQ1 Antibodies

Novel mutation in the Per-Arnt-Sim domain of KCNH2 causes a malignant form of long-QT syndrome

Suppression-Replacement Kcnq1 Gene Therapy For Type 1 Long Qt Syndrome

Altered neurological and neurobehavioral phenotypes in a mouse model of the recurrent KCNB1-p.R306C voltage-sensor variant